Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 3
1977 2
1981 1
1982 1
1983 2
1984 1
1987 1
1988 2
1989 1
1990 2
1992 3
1993 1
1996 1
1997 1
1998 2
1999 2
2001 3
2004 2
2005 3
2006 1
2007 5
2008 7
2009 9
2010 4
2011 8
2012 8
2013 8
2014 9
2015 11
2016 5
2017 4
2018 8
2019 4
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Among authors: klingensmith gj. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
They're still kids.
Zeitler PS, Klingensmith GJ. Zeitler PS, et al. Among authors: klingensmith gj. J Pediatr. 2009 Jan;154(1):7-9. doi: 10.1016/j.jpeds.2008.09.028. J Pediatr. 2009. PMID: 19187730 No abstract available.
Dyslipidemia in youth with diabetes: to treat or not to treat?
Maahs DM, Wadwa RP, Bishop F, Daniels SR, Rewers M, Klingensmith GJ. Maahs DM, et al. Among authors: klingensmith gj. J Pediatr. 2008 Oct;153(4):458-65. doi: 10.1016/j.jpeds.2008.05.062. J Pediatr. 2008. PMID: 18847618 Free PMC article. Review. No abstract available.
Can we get it right for youth with type 2 diabetes?
Tamborlane WV, Ruedy K, Van Name M, Klingensmith GJ. Tamborlane WV, et al. Among authors: klingensmith gj. Diabetes Res Clin Pract. 2014 Dec;106(3):643-4. doi: 10.1016/j.diabres.2014.11.003. Diabetes Res Clin Pract. 2014. PMID: 25488379 Review. No abstract available.
Type 2 diabetes in children and adolescents.
Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Rosenbloom AL, et al. Among authors: klingensmith gj. Pediatr Diabetes. 2009 Sep;10 Suppl 12:17-32. doi: 10.1111/j.1399-5448.2009.00584.x. Pediatr Diabetes. 2009. PMID: 19754615 Review. No abstract available.
Recent advances in insulin treatment of children.
Steck AK, Klingensmith GJ, Fiallo-Scharer R. Steck AK, et al. Among authors: klingensmith gj. Pediatr Diabetes. 2007 Oct;8 Suppl 6:49-56. doi: 10.1111/j.1399-5448.2007.00276.x. Pediatr Diabetes. 2007. PMID: 17727385 Review.
115 results